
"Supreme Court Scrutiny: Doctors' Limited Experience with Mifepristone and Reproductive Rights"
The Supreme Court is set to hear a case challenging the FDA's regulations on the abortion pill mifepristone, with 11 anti-abortion doctors and advocates claiming harm from patients' complications. Critics question the doctors' standing, as they do not prescribe the drug and lack direct experience with its complications. The case's outcome could impact abortion access, as medication abortions make up a significant portion of all abortions in the US. The case raises questions about standing and the potential for ideological organizations to challenge government decisions.

